Digital SP263 PD-L1 tumor cell scoring in non-small cell lung cancer achieves comparable outcome prediction to manual pathology scoring

被引：1
|
作者：
Prizant, Hen
Shamshoian, John
Abel, John
Beck, Andrew
Chambre, Laura
Hennek, Stephanie
Koeppen, Hartmut
Ruderman, Daniel
Das Thakur, Meghna
Montalto, Michael
Trotter, Benjamin
Wapinski, Ilan
Zou, Wei
Srivastava, Minu K.
Giltnane, Jennifer
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5358
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5358
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Inter-rater reliability of programmed death ligand 1 ( PD-L1) scoring using the VENTANA PD-L1 (SP263) assay in non-small cell lung cancer (NSCLC)
    Williams, G. H.
    Nicholson, A. G.
    Snead, D. R. J.
    Thunnissen, E.
    Lantuejoul, S.
    Cane, P.
    Kerr, K. M.
    Loddo, M.
    Scott, M.
    Scorer, P. W.
    Barker, C.
    ANNALS OF ONCOLOGY, 2018, 29
  • [2] A Machine Learning Based Algorithm for Automatic Scoring of PD-L1 SP263 in Non-Small-Cell Lung Carcinoma (NSCLC)
    Miri, Mohammad Saleh
    Nguyen, Kien
    Earley, Keith
    Selck, Stefanie
    Patil, Suhas
    Zuiderveld, Karel
    Manriquez, Guadalupe
    Hayden, Dorothy
    Vennapusa, Bharathi
    Guetter, Christoph
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1479 - 1480
  • [3] A Machine Learning Based Algorithm for Automatic Scoring of PD-L1 SP263 in Non-Small-Cell Lung Carcinoma (NSCLC)
    Miri, Mohammad Saleh
    Kien Nguyen
    Earley, Keith
    Selck, Stefanie
    Patil, Suhas
    Zuiderveld, Karel
    Manriquez, Guadalupe
    Hayden, Dorothy
    Vennapusa, Bharathi
    Guetter, Christoph
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1479 - 1480
  • [4] Clinical significance of ≥ 50% PD-L1 expression with the SP263 monoclonal antibody in non-small cell lung cancer patients
    Li, Wenbin
    Song, Peng
    Guo, Lei
    Liu, Xiuyun
    Guo, Changyuan
    Ying, Jianming
    Gao, Shugeng
    THORACIC CANCER, 2019, 10 (02) : 175 - 182
  • [5] Comparison of PD-L1 Assays in Non-small Cell Lung Cancer: 22C3 pharmDx and SP263
    Fujimoto, Daichi
    Yamashita, Daisuke
    Fukuoka, Junya
    Kitamura, Yuka
    Hosoya, Kazutaka
    Kawachi, Hayato
    Sato, Yuki
    Nagata, Kazuma
    Nakagawa, Atsushi
    Tachikawa, Ryo
    Date, Naoki
    Sakanoue, Ichiro
    Hamakawa, Hiroshi
    Takahashi, Yutaka
    Tomii, Keisuke
    ANTICANCER RESEARCH, 2018, 38 (12) : 6891 - 6895
  • [6] PD-L1 immunostaining scoring for non-small cell lung cancer based on immunosurveillance parameters
    Silva, Manuel A.
    Ryall, Karen A.
    Wilm, Claudia
    Caldara, Jenifer
    Grote, Hans Juergen
    Patterson-Kane, Janet C.
    PLOS ONE, 2018, 13 (06):
  • [7] Digital pathology to evaluate PD-L1 IHC scoring as a predictor of outcome with second-line avelumab treatment in patients with non-small cell lung cancer (NSCLC).
    Mrowiec, Thomas
    Svenson, Elena
    Gerhold-Ay, Aslihan
    Wolf, Corinna M.
    Grote, Hans Juergen
    Otte, Marcus
    Rolfe, P. Alexander
    Shah, Parantu K.
    von Heydebreck, Anja
    Scheuenpflug, Juergen
    Ruisi, Mary M.
    Labarta-Beceiro, Violeta
    Beeman, Glenn
    Cai, Ti
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Faster and Better: Artificial Intelligence Assisted PD-L1 Scoring in Non-Small Cell Lung Cancer
    Sjoblom, Nelli
    Laury, Anna
    Kovala, Marja
    Knuuttila, Anna
    Manninen, Anniina
    Blom, Sami
    Karjalainen, Marika
    Juhila, Juuso
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1318 - S1318
  • [9] Novel multiplex droplet digital PCR assay for scoring PD-L1 in non-small cell lung cancer biopsy specimens
    Vannitamby, Amanda
    Hendry, Shona
    Irving, Louis
    Steinfort, Daniel
    Bozinovski, Steven
    LUNG CANCER, 2019, 134 : 233 - 237
  • [10] Automated tumor proportion scoring for PD-L1 expression based on multistage ensemble strategy in non-small cell lung cancer
    Boju Pan
    Yuxin Kang
    Yan Jin
    Lin Yang
    Yushuang Zheng
    Lei Cui
    Jian Sun
    Jun Feng
    Yuan Li
    Lingchuan Guo
    Zhiyong Liang
    Journal of Translational Medicine, 19
12345